EMA's 2024 annual report offers insights into key initiatives and priority areas that guided our work in 2024.
The report highlights the outcomes of the evaluation and monitoring of human and veterinary medicines.
It features key figures and an interactive timeline with milestones from 2024.
Its timeline enables readers to explore each topic in depth by accessing relevant documents, audio-visual materials and infographics.
The report is available in two formats:
- Digital version: with a fresh layout and new interactive features
- PDF version: downloadable, printable format with figures and statistics on EMA's regulatory procedures and activities